This study aimed to determine the efficacy of personalized lifestyle interventions on NAFLD remission, and on the improvement of metabolic factors and Mac-2-binding protein glycosylated isomer (M2BPGi) in primary healthcare. This evidence concerns the gene LGALS3BP and metabolic dysfunction-associated steatotic liver disease.